Literature DB >> 11243302

Effect of familial hypertension on glomerular hemodynamics and tubulo-glomerular feedback after uninephrectomy.

E Guidi1, M G Cozzi, E E Minetti, G Civati, G Busnach, B Brando.   

Abstract

Familial hypertension, glomerular hemodynamic alterations, and dysregulation of tubulo-glomerular feedback (TGFB) have all been associated with the development of chronic renal failure. In the present study we evaluated renal and glomerular hemodynamics and TGFB responses in healthy kidney donors either with or without familial hypertension, before and after nephrectomy. Para-amino-hippurate plasma clearance (CPAH) and inulin plasma clearance (CInu) were measured in 15 kidney donors before and 1 year after nephrectomy. All subjects were normotensive and were kept in a sodium-replete state. Both clearances were measured after 40 min of constant infusion of PAH and Inu, as well as 20, 30, 50, and 60 min after the intravenous administration of acetazolamide (5 mg/kg). Glomerular hemodynamics were calculated by means of the Gomez formulae. Nephrectomy caused the expected decreases in CPAH and CInu and increase in the filtration fraction (all P < .0001). The decrease in renal resistances of the remaining kidney was greater at the afferent (-24%, P = .0075) than at the efferent arteriolar level (-17%, P < .0001). The TGFB activation was not altered by nephrectomy or by familial hypertension. Effective renal plasma flow (ERPF) decrease after TGFB activation appeared earlier than glomerular filtration rate (GFR) decrease before (P = .01), but not after, nephrectomy (P = .48). The presence of familial hypertension was associated with increased glomerular pressure (P = .0004). This study suggests that uninephrectomy in healthy human subjects causes a greater decrease in afferent arteriolar resistances, but that TGFB responses are not quantitatively altered. Familial hypertension is associated with a tendency toward higher glomerular pressures.

Entities:  

Mesh:

Year:  2001        PMID: 11243302     DOI: 10.1016/s0895-7061(00)01238-3

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  6 in total

1.  Effects of linagliptin on renal endothelial function in patients with type 2 diabetes: a randomised clinical trial.

Authors:  Christian Ott; Iris Kistner; Mirjam Keller; Stefanie Friedrich; Carsten Willam; Peter Bramlage; Roland E Schmieder
Journal:  Diabetologia       Date:  2016-09-01       Impact factor: 10.122

2.  Urinary endothelin-1-like immunoreactivity excretion in Wilms' tumor survivors.

Authors:  Alessio Imperiale; Catia Olianti; Gabriella Bernini; Angela Tamburini; Maria Silvia Tommasi; Giuseppe La Cava
Journal:  Pediatr Nephrol       Date:  2012-04-12       Impact factor: 3.714

3.  Effects of manidipine vs. amlodipine on intrarenal haemodynamics in patients with arterial hypertension.

Authors:  Christian Ott; Markus P Schneider; Ulrike Raff; Martin Ritt; Kristina Striepe; Marco Alberici; Roland E Schmieder
Journal:  Br J Clin Pharmacol       Date:  2013-01       Impact factor: 4.335

4.  Effects of the nitric oxide synthase inhibitor ronopterin (VAS203) on renal function in healthy volunteers.

Authors:  Christian Ott; Agnes Bosch; Nicole Winzer; Stephanie Friedrich; Reinhard Schinzel; Frank Tegtmeier; Roland E Schmieder
Journal:  Br J Clin Pharmacol       Date:  2019-02-28       Impact factor: 4.335

5.  Significant association between glycemic status and increased estimated postglomerular resistance in nondiabetic subjects - study of inulin and para-aminohippuric acid clearance in humans.

Authors:  Mari Yasumoto; Akihiro Tsuda; Eiji Ishimura; Hideki Uedono; Yoshiteru Ohno; Mitsuru Ichii; Akinobu Ochi; Shinya Nakatani; Katsuhito Mori; Junji Uchida; Masanori Emoto; Tatsuya Nakatani; Masaaki Inaba
Journal:  Physiol Rep       Date:  2015-03

6.  Effect of Acetazolamide on Obesity-Induced Glomerular Hyperfiltration: A Randomized Controlled Trial.

Authors:  Boris Zingerman; Michal Herman-Edelstein; Arie Erman; Sarit Bar Sheshet Itach; Yaacov Ori; Benaya Rozen-Zvi; Uzi Gafter; Avry Chagnac
Journal:  PLoS One       Date:  2015-09-14       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.